Research & Development

The focus of the Newport research and development strategy is on the innovation of the lead compound IAD. This development takes place on a number of different levels so as to maximise the knowledge of the molecule and to maximise the potential for breakthrough innovation with the molecule. These areas include:

Mechanism of Action studies
Formulation Development
Novel Clinical Indications for IAD to target unmet clinical need
Controlled and/or Sustained Release Formulation
Combination Therapy